Deep dive into fetal ventriculomegaly

News
Article
Contemporary OB/GYN JournalVol 70 No. 1
Volume 70
Issue 1

Fetal ventriculomegaly, a condition marked by the dilation of cerebral ventricles, is a common finding on second-trimester ultrasounds and requires careful evaluation to determine its causes, severity, and potential impact on neurological outcomes.

Ventriculomegaly is a term used to describe the dilation of the cerebral ventricles within the fetal brain. Ventriculomegaly can be caused by several different disorders, including structural brain malformations, genetic abnormalities, congenital infections, and teratogens.

Fetal ventriculomegaly is a relatively common finding on second-trimester obstetric ultrasound examination. The prevalence of ventriculomegaly is approximately 0.15% in the general obstetric population.1

Diagnosis of ventriculomegaly is usually initially made on ultrasound with routine prenatal screening. It is then further classified based on the severity of the enlargement. The diameter of the ventricles remains stable throughout pregnancy, with the upper limit of normal being less than 10 mm.1-6 Mild ventriculomegaly is a ventricular diameter between 10 and 12 mm. Moderate ventriculomegaly is a ventricular diameter of 13 to 15 mm. Severe ventriculomegaly, or hydrocephalus, is a ventricular diameter of greater than 15 mm (Figures 1 and 2).7

Another common ultrasound finding with ventriculomegaly is where the choroid plexus appears to fall toward or rest on the dependent wall of the lateral ventricle, resulting in an increased angle, or “dangling,” of the choroid plexus (Figure 3).8 Approximately half the cases of ventriculomegaly are unilateral, and the other half are bilateral.7,9,10 The causes and perinatal outcomes of unilateral and bilateral ventriculomegaly are similar, thus their management is the same.11

Isolated mild ventriculomegaly is usually a normal variant and is associated with normal neurological outcomes. Isolated moderate ventriculomegaly has also been associated with normal outcomes, although less likely as compared with mild.7 Pathologic ventriculomegaly can either be due to excessive cerebrospinal fluid (CSF) production, obstruction, or loss of cerebral tissue. As stated above, these pathologic causes include idiopathic or genetic and chromosomal disorders (commonly trisomy 21, 18, and 13).

Other genetic syndromes are also associated with ventriculomegaly, such as X-linked hydrocephalus and other microdeletions/microduplications. Congenital infections such as cytomegalovirus, toxoplasmosis, rubella, or Zika virus can cause ventriculomegaly by cerebral atrophy, or obstruction from fibrosis and inflammation. Structural malformations such as aqueductal stenosis, agenesis of the corpus callosum, and neural tube defects have all been associated with ventriculomegaly. Other causes include obstruction from mass effect, intracranial hemorrhage from vascular abnormalities, teratogens, and, although rare, excessive CSF production by a choroid plexus tumor.

The management of fetal ventriculomegaly depends on the underlying etiology and severity of the condition and typically requires a multidisciplinary approach involving obstetricians, maternal-fetal medicine specialists, pediatric neurologists, and genetic counselors. Therefore, the necessary recommended steps after initial diagnosis include a detailed anatomic survey to assess for any other central nervous system malformations, any other associated structural fetal malformations that are typically found with genetic syndromes or fetal infections,12-16 fetal biometry, as ventriculomegaly can be linked fetal growth restriction—especially if associated with a genetic abnormality,7 genetic counseling to offer diagnostic genetic testing for chromosomal microarray, infectious polymerase chain reaction, alpha-fetoprotein, and acetylcholinesterase if there is suspicion for a neural tube defect,17,18 and testing for single gene disorders or consideration for exome sequencing if initial genetic testing is normal.

MRI should be considered in cases of ventriculomegaly, especially in cases with no clear etiology or where ultrasound is not conclusive in ruling out other malformations. A meta-analysis that assessed the increased diagnostic yield of MRI based on the type of ultrasound assessment showed that MRI detected additional anomalies in 5% to 16% of fetuses with mild or moderate ventriculomegaly. These additional findings are vital for parental counseling and can change perinatal management in 3% to 5%.19 Given that neurological malformations can be associated with a wide range of pediatric outcomes from normal to severe neurological delays, prenatal counseling is often difficult, as it leaves many parental questions unanswered until after the fetus is born. Because of this, in situations such as isolated mild ventriculomegaly, confirmation of this through MRI can provide some relief to parents as the majority have normal long-term neurological outcomes. In addition, certain neurological findings, such as cortical or sulcation malformations, and migrational abnormalities may not be easily diagnosed on prenatal ultrasound but can be detected by MRI.20-22

Again, the prognosis is also dependent on the etiology and severity of ventriculomegaly. For example, if the etiology has been confirmed due to aneuploidy, then the parents should be informed that the prognosis is typically dependent on that specific aneuploidy. However, etiology cannot always be confirmed prenatally, and parents should be informed of the wide variation of outcomes. Neurological, motor, and cognitive delays are more likely with severe ventriculomegaly, with meta-analysis reporting rates as high as 58% as compared with greater than 90% in cases of isolated mild to moderate ventriculomegaly.13-15,17,23 The prognosis is also worse if there is the presence of other structural malformations or a progression of the ventriculomegaly as gestation advances.13,24,25

Sonographic follow-up and serial monitoring are recommended to evaluate progression or persistence. Isolated mild ventriculomegaly can also resolve throughout the pregnancy.26In a study involving 106 liveborn infants, ventriculomegaly showed varying trends during fetal development. Among these infants, 19 (18%) experienced an increase in ventriculomegaly before birth, whereas 37 (35%) remained stable and 50 (47%) either improved or resolved before birth.26 Of the cases where ventriculomegaly improved, 92% (46 of 50) had normal outcomes. This contrasts with outcomes in cases where ventriculomegaly remained stable (35%; 13 of 37) or worsened (21%; 4 of 19). Overall, the progression of ventriculomegaly before birth was linked to adverse outcomes in 44% of cases vs only 7% in cases where ventriculomegaly did not progress.

Consultation with a pediatric neurosurgeon may be advisable if ventriculomegaly shows signs of progression. Although rare, some newborns may require surgical procedures such as ventriculoperitoneal shunting; however, this intervention is still considered investigational.

Antepartum fetal testing, such as nonstress tests or biophysical profiles, has not been shown to provide clear benefits in pregnancies where fetal ventriculomegaly is isolated and there are no other fetal conditions (eg, growth restriction or low amniotic fluid levels) or pregnancy complications that are known to increase the risk of fetal loss.

The timing of delivery is typically based on usual obstetrical indications, as there is a lack of high-quality evidence that shows improved perinatal outcomes with earlier delivery, and there are known adverse neonatal outcomes with preterm delivery. Some authors have suggested earlier delivery in cases of progressive severe ventriculomegaly to expedite postnatal shunting.27 The mode of delivery is also typically based on usual obstetrical indications, as there is a paucity of data to show improved perinatal outcomes with cesarean section. For fetuses with macrocephaly, typically with head circumferences exceeding 40 cm, some authors suggest planned cesarean section.28

In conclusion, fetal ventriculomegaly is a multifaceted condition demanding thorough assessment and treatment to enhance outcomes for both the fetus and the family. Progress in prenatal imaging and genetic testing has enhanced our capacity to diagnose and define ventriculomegaly before birth, facilitating prompt intervention and well-informed decision-making. Ongoing research is essential to deepen our understanding of the root causes of ventriculomegaly and to devise more efficient treatments for those affected.

References

  1. Achiron R, Schimmel M, Achiron A, Mashiach S. Fetal mild idiopathic lateral ventriculomegaly: is there a correlation with fetal trisomy? Ultrasound Obstet Gynecol. 1993;3(2):89-92. doi:10.1046/j.1469-0705.1993.03020089.x
  2. Cardoza JD, Goldstein RB, Filly RA. Exclusion of fetal ventriculomegaly with a single measurement: the width of the lateral ventricular atrium. Radiology. 1988;169(3):711-714. doi:10.1148/radiology.169.3.3055034
  3. Pilu G, Reece EA, Goldstein I, Hobbins JC, Bovicelli L. Sonographic evaluation of the normal developmental anatomy of the fetal cerebral ventricles: II. the atria. Obstet Gynecol. 1989;73(2):250-256.
  4. Menkes JH, Sarnat HB. Neuroembryology, genetic programming, and malformations. In: Menkes JH, Sarnat HB, eds. Child Neurology, 6th ed. Lippincott Williams and Wilkins; 2000:354.
  5. Chasen ST, Chervenak FA, McCullough LB. The role of cephalocentesis in modern obstetrics. Am J Obstet Gynecol. 2001;185(3):734-736. doi:10.1067/mob.2001.117487
  6. Váradi V, Tóth Z, Török O, Papp Z. Heterogeneity and recurrence risk for congenital hydrocephalus (ventriculomegaly): a prospective study. Am J Med Genet. 1988;29(2):305-310. doi:10.1002/ajmg.1320290209
  7. Fox NS, Monteagudo A, Kuller JA, Craigo S, Norton ME; Society for Maternal-Fetal Medicine. Mild fetal ventriculomegaly: diagnosis, evaluation, and management. Am J Obstet Gynecol. 2018;219(1):B2-B9. doi:10.1016/j.ajog.2018.04.039
  8. Cardoza JD, Filly RA, Podrasky AE. The dangling choroid plexus: a sonographic observation of value in excluding ventriculomegaly. AJR Am J Roentgenol. 1988;151(4):767-770. doi:10.2214/ajr.151.4.767
  9. Falip C, Blanc N, Maes E, et al. Postnatal clinical and imaging follow-up of infants with prenatal isolated mild ventriculomegaly: a series of 101 cases. Pediatr Radiol. 2007;37(10):981-989. doi:10.1007/s00247-007-0582-2
  10. Griffiths PD, Brackley K, Bradburn M, et al. Anatomical subgroup analysis of the MERIDIAN cohort: ventriculomegaly. Ultrasound Obstet Gynecol. 2017;50(6):736-744. doi:10.1002/uog.17475
  11. Scala C, Familiari A, Pinas A, et al. Perinatal and long-term outcomes in fetuses diagnosed with isolated unilateral ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017;49(4):450-459. doi:10.1002/uog.15943
  12. Farrell TA, Hertzberg BS, Kliewer MA, Harris L, Paine SS. Fetal lateral ventricles: reassessment of normal values for atrial diameter at US. Radiology. 1994;193(2):409-411. doi:10.1148/radiology.193.2.7972754
  13. Gaglioti P, Danelon D, Bontempo S, Mombrò M, Cardaropoli S, Todros T. Fetal cerebral ventriculomegaly: outcome in 176 cases. Ultrasound Obstet Gynecol. 2005;25(4):372-377. doi:10.1002/uog.1857
  14. Gaglioti P, Oberto M, Todros T. The significance of fetal ventriculomegaly: etiology, short- and long-term outcomes. Prenat Diagn. 2009;29(4):381-388. doi:10.1002/pd.2195
  15. Sethna F, Tennant PWG, Rankin J, C Robson S. Prevalence, natural history, and clinical outcome of mild to moderate ventriculomegaly. Obstet Gynecol. 2011;117(4):867-876. doi:10.1097/AOG.0b013e3182117471
  16. Hannon T, Tennant PW, Rankin J, Robson SC. Epidemiology, natural history, progression, and postnatal outcome of severe fetal ventriculomegaly. Obstet Gynecol. 2012;120(6):1345-1353. doi:10.1097/aog.0b013e3182732b53
  17. Pagani G, Thilaganathan B, Prefumo F. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2014;44(3):254-260. doi:10.1002/uog.13364
  18. Palomaki GE, Bupp C, Gregg AR, et al. Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020;22(3):462-474. doi:10.1038/s41436-019-0681-0
  19. Di Mascio D, Sileo FG, Khalil A, et al. Role of magnetic resonance imaging in fetuses with mild or moderate ventriculomegaly in the era of fetal neurosonography: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;54(2):164-171. doi:10.1002/uog.20197
  20. Griffiths PD, Bradburn M, Campbell MJ, et al. Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study. Lancet. 2017;389(10068):538-546. doi:10.1016/S0140-6736(16)31723-8
  21. Rossi AC, Prefumo F. Additional value of fetal magnetic resonance imaging in the prenatal diagnosis of central nervous system anomalies: a systematic review of the literature. Ultrasound Obstet Gynecol. 2014;44(4):388-393. doi:10.1002/uog.13429
  22. ENSO Working Group. Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: international multicenter study. Ultrasound Obstet Gynecol. 2020;56(3):340-347. doi:10.1002/uog.21974
  23. Carta S, Kaelin Agten A, Belcaro C, Bhide A. Outcome of fetuses with prenatal diagnosis of isolated severe bilateral ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;52(2):165-173. doi:10.1002/uog.19038
  24. Futagi Y, Suzuki Y, Toribe Y, Morimoto K. Neurodevelopmental outcome in children with fetal hydrocephalus. Pediatr Neurol. 2002;27(2):111-116. doi:10.1016/s0887-8994(02)00395-8
  25. Breeze AC, Alexander PM, Murdoch EM, Missfelder-Lobos HH, Hackett GA, Lees CC. Obstetric and neonatal outcomes in severe fetal ventriculomegaly. Prenat Diagn. 2007;27(2):124-129. doi:10.1002/pd.1624
  26. Melchiorre K, Bhide A, Gika AD, Pilu G, Papageorghiou AT. Counseling in isolated mild fetal ventriculomegaly. Ultrasound Obstet Gynecol. 2009;34(2):212-224. doi:10.1002/uog.7307
  27. McGirt MJ, Leveque JC, Wellons JC 3rd, et al. Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience. Pediatr Neurosurg. 2002;36(5):248-255. doi:10.1159/000058428
  28. Shinar S, Chitayat D, Shannon P, Blaser S. Fetal macrocephaly: pathophysiology, prenatal diagnosis and management. Prenat Diagn. 2023;43(13):1650-1661. doi:10.1002/pd.6473
Recent Videos
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
Screening-to-diagnosis interval vital for gestational diabetes outcomes | Image Credit: ultracon2024.eventscribe.net
Henri M. Rosenberg, MD
Study explores the limits of neighborhood data in predicting preterm birth | Image Credit: linkedin.com
Integrase inhibitors not linked to neonatal weight | Image Credit: linkedin.com
How AI is revolutionizing prenatal detection of congenital heart defects | Image Credit: mfmnyc.com/team.
Dr. Wennerholm highlights future opportunities for managing prolonged pregnancy | Image Credit: gu.se/en/about/find-staff.
Related Content
© 2025 MJH Life Sciences

All rights reserved.